These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 22406360)

  • 1. Identification of biomarkers to distinguish clear cell sarcoma from malignant melanoma.
    Yang L; Chen Y; Cui T; Knösel T; Zhang Q; Geier C; Katenkamp D; Petersen I
    Hum Pathol; 2012 Sep; 43(9):1463-70. PubMed ID: 22406360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clear cell melanoma: a cutaneous clear cell malignancy.
    Pletneva MA; Andea A; Palanisamy N; Betz BL; Carskadon S; Wang M; Patel RM; Fullen DR; Harms PW
    Arch Pathol Lab Med; 2014 Oct; 138(10):1328-36. PubMed ID: 25268196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of mutations of the BRAF gene in malignant melanoma of soft parts (clear cell sarcoma of tendons and aponeuroses).
    Panagopoulos I; Mertens F; Isaksson M; Mandahl N
    Cancer Genet Cytogenet; 2005 Jan; 156(1):74-6. PubMed ID: 15588860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant melanoma is genetically distinct from clear cell sarcoma of tendons and aponeurosis (malignant melanoma of soft parts).
    Langezaal SM; Graadt van Roggen JF; Cleton-Jansen AM; Baelde JJ; Hogendoorn PC
    Br J Cancer; 2001 Feb; 84(4):535-8. PubMed ID: 11207050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic utility of EWS break-apart fluorescence in situ hybridization in distinguishing between non-cutaneous melanoma and clear cell sarcoma.
    Song JS; Choi J; Kim JH; Jang SJ; Cho KJ
    Pathol Int; 2010 Sep; 60(9):608-13. PubMed ID: 20712646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clear cell sarcoma of soft tissue: a clinicopathologic, immunohistochemical, and molecular analysis of 33 cases.
    Hisaoka M; Ishida T; Kuo TT; Matsuyama A; Imamura T; Nishida K; Kuroda H; Inayama Y; Oshiro H; Kobayashi H; Nakajima T; Fukuda T; Ae K; Hashimoto H
    Am J Surg Pathol; 2008 Mar; 32(3):452-60. PubMed ID: 18300804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marked genetic differences between BRAF and NRAS mutated primary melanomas as revealed by array comparative genomic hybridization.
    Lázár V; Ecsedi S; Vízkeleti L; Rákosy Z; Boross G; Szappanos B; Bégány A; Emri G; Adány R; Balázs M
    Melanoma Res; 2012 Jun; 22(3):202-14. PubMed ID: 22456166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EWS-ATF1 fusion transcripts in gastrointestinal tumors previously diagnosed as malignant melanoma.
    Covinsky M; Gong S; Rajaram V; Perry A; Pfeifer J
    Hum Pathol; 2005 Jan; 36(1):74-81. PubMed ID: 15712185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EWSR1-CREB1 is the predominant gene fusion in angiomatoid fibrous histiocytoma.
    Antonescu CR; Dal Cin P; Nafa K; Teot LA; Surti U; Fletcher CD; Ladanyi M
    Genes Chromosomes Cancer; 2007 Dec; 46(12):1051-60. PubMed ID: 17724745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastrointestinal melanoma or clear cell sarcoma? Molecular evaluation of 7 cases previously diagnosed as malignant melanoma.
    Lyle PL; Amato CM; Fitzpatrick JE; Robinson WA
    Am J Surg Pathol; 2008 Jun; 32(6):858-66. PubMed ID: 18408594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous melanoma subtypes show different BRAF and NRAS mutation frequencies.
    Saldanha G; Potter L; Daforno P; Pringle JH
    Clin Cancer Res; 2006 Aug; 12(15):4499-505. PubMed ID: 16899595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visceral clear cell sarcoma of soft tissue with confirmation by EWS-ATF1 fusion detection.
    Granville L; Hicks J; Popek E; Dishop M; Tatevian N; Lopez-Terrada D
    Ultrastruct Pathol; 2006; 30(1):111-8. PubMed ID: 16517477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of specific gene rearrangements by fluorescence in situ hybridization in 16 cases of clear cell sarcoma of soft tissue and 6 cases of clear cell sarcoma-like gastrointestinal tumor.
    Segawa K; Sugita S; Aoyama T; Kubo T; Asanuma H; Sugawara T; Ito Y; Tsujiwaki M; Fujita H; Emori M; Hasegawa T
    Diagn Pathol; 2018 Sep; 13(1):73. PubMed ID: 30219084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NRAS and BRAF mutations in melanoma tumours in relation to clinical characteristics: a study based on mutation screening by pyrosequencing.
    Edlundh-Rose E; Egyházi S; Omholt K; Månsson-Brahme E; Platz A; Hansson J; Lundeberg J
    Melanoma Res; 2006 Dec; 16(6):471-8. PubMed ID: 17119447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clear cell sarcoma of soft tissue: diagnostic utility of fluorescence in situ hybridization and reverse transcriptase polymerase chain reaction.
    Curry CV; Dishop MK; Hicks MJ; Naeem R; Reed JA; López-Terrada DH
    J Cutan Pathol; 2008 Apr; 35(4):411-7. PubMed ID: 18333903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human malignant melanoma: detection of BRAF- and c-kit-activating mutations by high-resolution amplicon melting analysis.
    Willmore-Payne C; Holden JA; Tripp S; Layfield LJ
    Hum Pathol; 2005 May; 36(5):486-93. PubMed ID: 15948115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression profiling of t(12;22) positive clear cell sarcoma of soft tissue cell lines reveals characteristic up-regulation of potential new marker genes including ERBB3.
    Schaefer KL; Brachwitz K; Wai DH; Braun Y; Diallo R; Korsching E; Eisenacher M; Voss R; Van Valen F; Baer C; Selle B; Spahn L; Liao SK; Lee KA; Hogendoorn PC; Reifenberger G; Gabbert HE; Poremba C
    Cancer Res; 2004 May; 64(10):3395-405. PubMed ID: 15150091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of clear cell sarcoma by real-time reverse transcriptase-polymerase chain reaction analysis of paraffin embedded tissues: clinicopathologic and molecular analysis of 44 patients from the French sarcoma group.
    Coindre JM; Hostein I; Terrier P; Bouvier-Labit C; Collin F; Michels JJ; Trassard M; Marques B; Ranchere D; Guillou L
    Cancer; 2006 Sep; 107(5):1055-64. PubMed ID: 16878328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcome and pathological features associated with NRAS mutation in cutaneous melanoma.
    Devitt B; Liu W; Salemi R; Wolfe R; Kelly J; Tzen CY; Dobrovic A; McArthur G
    Pigment Cell Melanoma Res; 2011 Aug; 24(4):666-72. PubMed ID: 21615881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous clear cell sarcoma: a clinicopathologic, immunohistochemical, and molecular analysis of 12 cases emphasizing its distinction from dermal melanoma.
    Hantschke M; Mentzel T; Rütten A; Palmedo G; Calonje E; Lazar AJ; Kutzner H
    Am J Surg Pathol; 2010 Feb; 34(2):216-22. PubMed ID: 20087159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.